(Des Moines, IA) Following the announcement Friday that the Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA) have lifted the pause on the administration of the Johnson & Johnson vaccine, the Iowa Department of Public Health (IDPH) recommends that any vaccine provider in the state who has available Johnson & Johnson vaccine resume administration, effective immediately. 

The pause was recommended after reports of six cases of a rare and severe type of blood clot in individuals following administration of the Johnson & Johnson vaccine. The FDA and CDC are confident that the vaccine is safe and effective in preventing COVID-19 symptoms. They have stated that they will remain vigilant in investigating the risk of TTS blod clots but data suggests the risk is very low.

More information can be found on the CDC website here.